FWA Insights: Uncovering improper billing in urine drug screens

Improper billing practices and schemes related to urine drug screens (UDS) are common, requiring investigative resources to detect potential fraud, waste, and abuse (FWA). Though the Centers for Medicare & Medicaid Services (CMS) regulates human lab samples through strict guidelines outlined in the required Clinical Laboratory Improvements Amendmen...

• Published date: 17-07-2025 02:34 PM